vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and DiamondRock Hospitality Co (DRH). Click either name above to swap in a different company.
DiamondRock Hospitality Co is the larger business by last-quarter revenue ($274.5M vs $196.0M, roughly 1.4× Axsome Therapeutics, Inc.). DiamondRock Hospitality Co runs the higher net margin — 9.5% vs -14.6%, a 24.1% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -1.6%). DiamondRock Hospitality Co produced more free cash flow last quarter ($47.3M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 3.5%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
DiamondRock Hospitality Co is a US-based real estate investment trust owning and operating a portfolio of premium upscale hotels and resorts. Its properties are mainly located in major urban tourist and business hubs nationwide, catering to both leisure and corporate clientele seeking high-quality accommodation services.
AXSM vs DRH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $274.5M |
| Net Profit | $-28.6M | $26.2M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 8.9% |
| Net Margin | -14.6% | 9.5% |
| Revenue YoY | 65.0% | -1.6% |
| Net Profit YoY | 61.9% | 333.2% |
| EPS (diluted) | $-0.55 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $274.5M | ||
| Q3 25 | $171.0M | $285.4M | ||
| Q2 25 | $150.0M | $305.7M | ||
| Q1 25 | $121.5M | $254.9M | ||
| Q4 24 | $118.8M | $279.1M | ||
| Q3 24 | $104.8M | $285.1M | ||
| Q2 24 | $87.2M | $309.3M | ||
| Q1 24 | $75.0M | $256.4M |
| Q4 25 | $-28.6M | $26.2M | ||
| Q3 25 | $-47.2M | $22.5M | ||
| Q2 25 | $-48.0M | $40.8M | ||
| Q1 25 | $-59.4M | $11.9M | ||
| Q4 24 | $-74.9M | $-11.2M | ||
| Q3 24 | $-64.6M | $26.4M | ||
| Q2 24 | $-79.3M | $24.5M | ||
| Q1 24 | $-68.4M | $8.3M |
| Q4 25 | -13.8% | 8.9% | ||
| Q3 25 | -27.0% | 8.1% | ||
| Q2 25 | -24.5% | 13.7% | ||
| Q1 25 | -46.9% | 4.3% | ||
| Q4 24 | -61.1% | -3.7% | ||
| Q3 24 | -59.8% | 9.5% | ||
| Q2 24 | -89.5% | 8.4% | ||
| Q1 24 | -89.7% | 2.8% |
| Q4 25 | -14.6% | 9.5% | ||
| Q3 25 | -27.6% | 7.9% | ||
| Q2 25 | -32.0% | 13.4% | ||
| Q1 25 | -48.9% | 4.7% | ||
| Q4 24 | -63.1% | -4.0% | ||
| Q3 24 | -61.7% | 9.3% | ||
| Q2 24 | -91.0% | 7.9% | ||
| Q1 24 | -91.1% | 3.2% |
| Q4 25 | $-0.55 | $0.12 | ||
| Q3 25 | $-0.94 | $0.10 | ||
| Q2 25 | $-0.97 | $0.18 | ||
| Q1 25 | $-1.22 | $0.04 | ||
| Q4 24 | $-1.54 | $-0.06 | ||
| Q3 24 | $-1.34 | $0.11 | ||
| Q2 24 | $-1.67 | $0.10 | ||
| Q1 24 | $-1.44 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $68.1M |
| Total DebtLower is stronger | — | $1.1B |
| Stockholders' EquityBook value | $88.3M | $1.4B |
| Total Assets | $689.8M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.76× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $68.1M | ||
| Q3 25 | $325.3M | $145.3M | ||
| Q2 25 | $303.0M | $52.4M | ||
| Q1 25 | $300.9M | $100.6M | ||
| Q4 24 | $315.4M | $81.4M | ||
| Q3 24 | $327.3M | $75.3M | ||
| Q2 24 | $315.7M | $125.2M | ||
| Q1 24 | $331.4M | $120.1M |
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $88.3M | $1.4B | ||
| Q3 25 | $73.7M | $1.6B | ||
| Q2 25 | $73.1M | $1.6B | ||
| Q1 25 | $53.2M | $1.6B | ||
| Q4 24 | $57.0M | $1.6B | ||
| Q3 24 | $92.9M | $1.6B | ||
| Q2 24 | $102.9M | $1.6B | ||
| Q1 24 | $144.0M | $1.6B |
| Q4 25 | $689.8M | $3.0B | ||
| Q3 25 | $669.3M | $3.1B | ||
| Q2 25 | $639.8M | $3.1B | ||
| Q1 25 | $596.7M | $3.1B | ||
| Q4 24 | $568.5M | $3.2B | ||
| Q3 24 | $561.5M | $3.2B | ||
| Q2 24 | $548.2M | $3.2B | ||
| Q1 24 | $545.7M | $3.2B |
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.71× | ||
| Q1 24 | — | 0.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $67.9M |
| Free Cash FlowOCF − Capex | $-18.7M | $47.3M |
| FCF MarginFCF / Revenue | -9.6% | 17.2% |
| Capex IntensityCapex / Revenue | 0.0% | 7.5% |
| Cash ConversionOCF / Net Profit | — | 2.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $162.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $67.9M | ||
| Q3 25 | $1.0M | $74.6M | ||
| Q2 25 | $-32.4M | $73.6M | ||
| Q1 25 | $-43.4M | $27.6M | ||
| Q4 24 | $-26.2M | $75.8M | ||
| Q3 24 | $-18.6M | $61.7M | ||
| Q2 24 | $-30.1M | $55.7M | ||
| Q1 24 | $-53.5M | $31.2M |
| Q4 25 | $-18.7M | $47.3M | ||
| Q3 25 | $988.0K | $54.9M | ||
| Q2 25 | $-32.4M | $57.9M | ||
| Q1 25 | $-43.7M | $2.0M | ||
| Q4 24 | $-26.2M | $52.6M | ||
| Q3 24 | $-18.7M | $39.0M | ||
| Q2 24 | $-30.2M | $38.8M | ||
| Q1 24 | $-53.6M | $12.4M |
| Q4 25 | -9.6% | 17.2% | ||
| Q3 25 | 0.6% | 19.2% | ||
| Q2 25 | -21.6% | 18.9% | ||
| Q1 25 | -36.0% | 0.8% | ||
| Q4 24 | -22.1% | 18.9% | ||
| Q3 24 | -17.9% | 13.7% | ||
| Q2 24 | -34.6% | 12.5% | ||
| Q1 24 | -71.4% | 4.8% |
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.0% | 6.9% | ||
| Q2 25 | 0.0% | 5.1% | ||
| Q1 25 | 0.3% | 10.0% | ||
| Q4 24 | 0.0% | 8.3% | ||
| Q3 24 | 0.1% | 7.9% | ||
| Q2 24 | 0.1% | 5.5% | ||
| Q1 24 | 0.1% | 7.4% |
| Q4 25 | — | 2.59× | ||
| Q3 25 | — | 3.31× | ||
| Q2 25 | — | 1.80× | ||
| Q1 25 | — | 2.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.33× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 3.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
DRH
| Occupancy | $178.2M | 65% |
| Food And Beverage | $68.7M | 25% |
| Hotel Owned | $27.7M | 10% |
